Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Timely and aggressive treatment is crucial for improving outcomes in severe complications of adult-onset Still's disease.

Ayurvedic methods successfully treated severe acne in a patient.

Cyclosporine can treat skin conditions but needs careful monitoring for side effects.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

Post-void residual volume does not predict worsening urological symptoms in multiple sclerosis patients.

PKM2 is a promising target for heart repair and regeneration.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Tacrolimus is a better option than cyclosporine due to fewer side effects.

In 2019, dermatology and venereology improved skin cancer imaging, advanced in treating skin conditions like psoriasis, and explored the skin microbiome's role in diseases.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

The article suggests managing interferon beta therapy side effects in MS with dose adjustments, medications, and patient education.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

Nanofat grafting is better for delicate areas and combining it with lipofilling might improve hair loss treatment.

Beta-blockers and anti-anginal medications have various side effects and interactions that require careful monitoring and individualized treatment.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Dutasteride and finasteride have equal safety for treating BPH without increased heart risk.

Higher stress levels were found about two weeks before a heart attack.

People with alopecia areata have a higher risk of stroke.

Low testosterone increases kidney stone risk in men not on testosterone therapy.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

Taking vitamin C and vitamin E twice a day can help prevent sunburn and DNA damage from UVB exposure.

Testosterone's effects on COVID-19 are unclear and need more research.

Alpha-blockers and 5-alpha reductase inhibitors don't significantly increase dementia risk.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

The study suggests that acne keloidalis nuchae is linked to conditions like pseudofolliculitis barbae, scalp infections, metabolic syndrome, and is more common in males with an average onset age of 25.4 years.

Skin cancer in sun-exposed areas is more likely to come back.

Most hospitalized COVID-19 patients had long-term symptoms like fatigue and hair loss, with women and those sicker during hospitalization at higher risk.

Alopecia areata does not increase the risk of blood clots.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.